Background: We aim to identify and analyze the expression of dyregulated RNAs in colorectal cancer (CRC).
Methods: We selected a panel of RNAs specific to CRC composed of Nucleosome Assembly Protein 1 Like 2 (NAP1L2) mRNA, small nucleolar RNA host gene 14 ( and homo sapiens microRNA-3940-5p(hsa-miRNA-3940-5p) from genetic and epigenetic databases. Validation of the chosen RNAs was achieved by real time quantitative PCR in sera of patients with CRC, versus controls groups (benign lesions and healthy individual).
Results: We found that , hsa-miRNA-3940-5p and mRNA had an excellent performance characteristics and more superior than CEA, and CA19.9 for differentiating CRC from controls. Combined expression of hsa-miR-3940-5p and mRNA had reached 100% sensitivity with accuracy 93%. Interestingly, serum hsa-miRNA-3940-5p could be an independent prognostic factor in CRC.
Conclusion: The extracellular hsa-miR-3940-5p - mRNA may aid in CRC management.KEY MESSAGESThe extracellular RNAs provide a potential class of noninvasive biomarkers with high specificity, accuracy and stability for detection of CRC.We used data analysis followed by qPCR for detection of differential NAP1L2 gene expression with the selected epigenetic regulators.Our data presented interesting biomarker panel (NAP1L2 gene, l and hsa-miR-3940-5p) that may be potential for CRC diagnosis and prognosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/13813455.2019.1650070 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!